Vertex Pharmaceuticals, Inc. (VRTX)
444.55
+7.54
(+1.73%)
USD |
NASDAQ |
Dec 10, 16:00
445.58
+1.03
(+0.23%)
After-Hours: 16:21
Vertex Pharmaceuticals Profit Margin (Quarterly): 34.76% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc. | 21.32% |
| Amgen, Inc. | 33.55% |
| Eli Lilly & Co. | 31.72% |
| Regeneron Pharmaceuticals, Inc. | 38.89% |
| Moderna, Inc. | -19.68% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 22.13% |
| Return on Assets | 15.69% |
| Return on Invested Capital | 20.08% |
| Gross Profit Margin (Quarterly) | 86.69% |
| Operating Margin (Quarterly) | 41.02% |
| Return on Net Operating Assets | 48.77% |